Clinical trial
Multi-center, Prospective, Randomized, Controlled, Non-Inferiority, Clinical Trial of Chronic Afferent Nerve Stimulation (CAN-Stim) of the Tibial Nerve Versus Sacral Nerve Stimulation (SNS) in the Treatment of Urinary Urgency Incontinence Resulting From Refractory Overactive Bladder (OAB)
NCT02577302 is registered in ClinicalTrials.gov with Uro Medical Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-center, Prospective, Randomized, Controlled, Non-Inferiority, Clinical Trial of Chronic Afferent Nerve Stimulation (CAN-Stim) of the Tibial Nerve Versus Sacral Nerve Stimulation (SNS) in the Treatment of Urinary Urgency Incontinence Resulting From Refractory Overactive Bladder (OAB)
- Lead sponsor
- Uro Medical Corporation
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 21, 2018
- Completion date
- October 31, 2025
- Enrollment
- 200 (estimated)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.